Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain

The anthrax lethal toxin consists of protective antigen (PA) and lethal factor (LF). Understanding both the PA pore formation and LF translocation through the PA pore is crucial to mitigating and perhaps preventing anthrax disease. To better understand the interactions of the LF-PA engagement comple...

Full description

Bibliographic Details
Main Authors: Alexandra J. Machen, Narahari Akkaladevi, Caleb Trecazzi, Pierce T. O’Neil, Srayanta Mukherjee, Yifei Qi, Rebecca Dillard, Wonpil Im, Edward P. Gogol, Tommi A. White, Mark T. Fisher
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/9/10/298
id doaj-fede19d32f3a48ffa74c7d3b15e73737
record_format Article
spelling doaj-fede19d32f3a48ffa74c7d3b15e737372020-11-25T00:10:11ZengMDPI AGToxins2072-66512017-09-0191029810.3390/toxins9100298toxins9100298Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal DomainAlexandra J. Machen0Narahari Akkaladevi1Caleb Trecazzi2Pierce T. O’Neil3Srayanta Mukherjee4Yifei Qi5Rebecca Dillard6Wonpil Im7Edward P. Gogol8Tommi A. White9Mark T. Fisher10Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USADepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USADepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USADepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USADepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USADepartments of Biological Sciences and Bioengineering, Lehigh University, Bethlehem, PA 18015, USANational Center for Macromolecular Imaging, Baylor University, Houston TX 77030, USADepartments of Biological Sciences and Bioengineering, Lehigh University, Bethlehem, PA 18015, USADepartment of Biological Sciences, University of Missouri-Kansas City, Kansas City, MO 64110, USADepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USADepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USAThe anthrax lethal toxin consists of protective antigen (PA) and lethal factor (LF). Understanding both the PA pore formation and LF translocation through the PA pore is crucial to mitigating and perhaps preventing anthrax disease. To better understand the interactions of the LF-PA engagement complex, the structure of the LFN-bound PA pore solubilized by a lipid nanodisc was examined using cryo-EM. CryoSPARC was used to rapidly sort particle populations of a heterogeneous sample preparation without imposing symmetry, resulting in a refined 17 Å PA pore structure with 3 LFN bound. At pH 7.5, the contributions from the three unstructured LFN lysine-rich tail regions do not occlude the Phe clamp opening. The open Phe clamp suggests that, in this translocation-compromised pH environment, the lysine-rich tails remain flexible and do not interact with the pore lumen region.https://www.mdpi.com/2072-6651/9/10/298anthrax toxinlethal factorprotective antigenpore formationtranslocationnanodisccryo-EMcryoSPARC
collection DOAJ
language English
format Article
sources DOAJ
author Alexandra J. Machen
Narahari Akkaladevi
Caleb Trecazzi
Pierce T. O’Neil
Srayanta Mukherjee
Yifei Qi
Rebecca Dillard
Wonpil Im
Edward P. Gogol
Tommi A. White
Mark T. Fisher
spellingShingle Alexandra J. Machen
Narahari Akkaladevi
Caleb Trecazzi
Pierce T. O’Neil
Srayanta Mukherjee
Yifei Qi
Rebecca Dillard
Wonpil Im
Edward P. Gogol
Tommi A. White
Mark T. Fisher
Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain
Toxins
anthrax toxin
lethal factor
protective antigen
pore formation
translocation
nanodisc
cryo-EM
cryoSPARC
author_facet Alexandra J. Machen
Narahari Akkaladevi
Caleb Trecazzi
Pierce T. O’Neil
Srayanta Mukherjee
Yifei Qi
Rebecca Dillard
Wonpil Im
Edward P. Gogol
Tommi A. White
Mark T. Fisher
author_sort Alexandra J. Machen
title Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain
title_short Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain
title_full Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain
title_fullStr Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain
title_full_unstemmed Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain
title_sort asymmetric cryo-em structure of anthrax toxin protective antigen pore with lethal factor n-terminal domain
publisher MDPI AG
series Toxins
issn 2072-6651
publishDate 2017-09-01
description The anthrax lethal toxin consists of protective antigen (PA) and lethal factor (LF). Understanding both the PA pore formation and LF translocation through the PA pore is crucial to mitigating and perhaps preventing anthrax disease. To better understand the interactions of the LF-PA engagement complex, the structure of the LFN-bound PA pore solubilized by a lipid nanodisc was examined using cryo-EM. CryoSPARC was used to rapidly sort particle populations of a heterogeneous sample preparation without imposing symmetry, resulting in a refined 17 Å PA pore structure with 3 LFN bound. At pH 7.5, the contributions from the three unstructured LFN lysine-rich tail regions do not occlude the Phe clamp opening. The open Phe clamp suggests that, in this translocation-compromised pH environment, the lysine-rich tails remain flexible and do not interact with the pore lumen region.
topic anthrax toxin
lethal factor
protective antigen
pore formation
translocation
nanodisc
cryo-EM
cryoSPARC
url https://www.mdpi.com/2072-6651/9/10/298
work_keys_str_mv AT alexandrajmachen asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT narahariakkaladevi asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT calebtrecazzi asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT piercetoneil asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT srayantamukherjee asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT yifeiqi asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT rebeccadillard asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT wonpilim asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT edwardpgogol asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT tommiawhite asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
AT marktfisher asymmetriccryoemstructureofanthraxtoxinprotectiveantigenporewithlethalfactornterminaldomain
_version_ 1725408910202896384